Literature DB >> 3180096

A murine model of experimental metastasis to bone and bone marrow.

F Arguello1, R B Baggs, C N Frantz.   

Abstract

Bone is a common site of metastasis in human cancer. A major impediment to understanding the pathogenesis of bone metastasis has been the lack of an appropriate animal model. In this paper, we describe an animal model in which B16 melanoma cells injected in the left cardiac ventricle reproducibly colonize specific sites of the skeletal system of mice. Injection of 10(5) cells resulted in melanotic tumor colonies in most organs, including the skeletal system. Injection of 10(4) or fewer cells resulted in experimental metastasis almost entirely restricted to the skeletal system and ovary. In contrast, i.v. injection of 10(5) cells resulted in tumor colonies in the lung only. Left cardiac injection of 10(2) cells caused bone colonization, but the same number of cells injected i.v. did not colonize the lung. The number of bones with tumor colonies increased with increasing number of cells injected. Melanotic tumor colonies in the bone were characteristically distributed in the metaphysis of long bones and in the periphery of flat bones. Most animals developed paraplegia due to spinal cord compression by bony metastasis to the spine. Tumor colonization of bone occurred only in regions of bone containing hematopoietic bone marrow. This suggests that the injected tumor cells lodge, survive in the hematopoietic bone marrow environment, and grow to destroy adjacent bone. This experimental model of metastasis to bone will facilitate future studies of the pathophysiology and treatment of bone and bone marrow metastasis.

Entities:  

Mesh:

Year:  1988        PMID: 3180096

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  112 in total

1.  Urokinase-receptor/integrin complexes are functionally involved in adhesion and progression of human breast cancer in vivo.

Authors:  G van der Pluijm; B Sijmons; H Vloedgraven; C van der Bent; J W Drijfhout; J Verheijen; P Quax; M Karperien; S Papapoulos; C Löwik
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

2.  The ARF tumor suppressor inhibits tumor cell colonization independent of p53 in a novel mouse model of pancreatic ductal adenocarcinoma metastasis.

Authors:  Viviane Palhares Muniz; J Matthew Barnes; Seema Paliwal; Xuefeng Zhang; Xiaoyun Tang; Songhai Chen; Kokou D Zamba; Joseph J Cullen; David K Meyerholz; Shari Meyers; J Nathan Davis; Steven R Grossman; Michael D Henry; Dawn E Quelle
Journal:  Mol Cancer Res       Date:  2011-06-02       Impact factor: 5.852

Review 3.  Bone cancer pain.

Authors:  Juan Miguel Jimenez-Andrade; William G Mantyh; Aaron P Bloom; Alice S Ferng; Christopher P Geffre; Patrick W Mantyh
Journal:  Ann N Y Acad Sci       Date:  2010-06       Impact factor: 5.691

4.  HTLV-1 Tax transgenic mice develop spontaneous osteolytic bone metastases prevented by osteoclast inhibition.

Authors:  Ling Gao; Hongju Deng; Haibo Zhao; Angela Hirbe; John Harding; Lee Ratner; Katherine Weilbaecher
Journal:  Blood       Date:  2005-08-23       Impact factor: 22.113

5.  Override of the osteoclast defect in osteopontin-deficient mice by metastatic tumor growth in the bone.

Authors:  Tajneen Natasha; Misty Kuhn; Owen Kelly; Susan R Rittling
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

6.  Extracellular engagement of alpha6 integrin inhibited urokinase-type plasminogen activator-mediated cleavage and delayed human prostate bone metastasis.

Authors:  Michael O Ports; Ray B Nagle; Gerald D Pond; Anne E Cress
Journal:  Cancer Res       Date:  2009-06-02       Impact factor: 12.701

7.  Exogenous MC3T3 preosteoblasts migrate systemically and mitigate the adverse effects of wear particles.

Authors:  Kate Fritton; Pei-Gen Ren; Emmanuel Gibon; Allison J Rao; Ting Ma; Sandip Biswal; Sanjiv S Gambhir; Stuart B Goodman
Journal:  Tissue Eng Part A       Date:  2012-08-14       Impact factor: 3.845

8.  Use of low-molecular-weight heparin to decrease mortality in mice after intracardiac injection of tumor cells.

Authors:  Kim L Stocking; Jon C Jones; Nancy E Everds; Bernard S Buetow; Martine P Roudier; Robert E Miller
Journal:  Comp Med       Date:  2009-02       Impact factor: 0.982

9.  The effects of Hsp90 expression alteration on spinal metastases of breast carcinoma.

Authors:  Wangjun Yan; Jianru Xiao; Tielong Liu; Wending Huang; Xinghai Yang; Zhipeng Wu; Quan Huang; Ming Qian
Journal:  Tumour Biol       Date:  2013-03-01

10.  A murine model for bone marrow metastasis established by an i.v. injection of C-1300 neuroblastoma in A/J mice.

Authors:  M Iwakawa; K Ando; H Ohkawa; S Koike; Y J Chen
Journal:  Clin Exp Metastasis       Date:  1994-05       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.